| Literature DB >> 27995001 |
Fikri Kundes1, Metin Kement1, Kenan Cetin1, Levent Kaptanoglu1, Aytaç Kocaoglu1, Mehmet Karahan1, Serkan Fatih Yegen1, Ali Emre Atici1, Osman Civil1, Mehmet Eser1, Tebessum Cakir1, Nejdet Bildik1.
Abstract
BACKGROUND: The aim of our study is to evaluate perioperative and mid-term oncologic outcomes of the patients with colorectal cancer, who underwent emergent curative surgery.Entities:
Keywords: Colon cancers; Colorectal cancers; Emergency surgery; Rectal cancer
Year: 2016 PMID: 27995001 PMCID: PMC5125280 DOI: 10.1186/s40064-016-3725-9
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Fig. 1Twenty three (31.1%) and 31 (13%) patients were excluded for various reasons in emergent and elective groups, respectively
Demographic and clinical characteristics of the patients
| Parameters | Emergent group | Elective group | P value |
|---|---|---|---|
| Mean age ± SD years | 66.4 ± 14.1 | 59 ± 11.3 | 0.02 |
| Gender (M, %) | 32 (62.7) | 122 (58.9) | 0.64 |
| ASA class III (%) | 26 (51) | 73 (35.3) | 0.038 |
| Ostomy (%) | 22 (43.1) | 24 (11.6) | <0.0001 |
| Transfusion (%) | 10 (19.6) | 17 (8.2) | 0.017 |
| Surgical complication (%) | 34 (66.7) | 73 (35.3) | <0.0001 |
| ICU (%) | 27 (52.9) | 52 (25.1) | <0.0001 |
| Early mortality (%) | 7 (13.7) | 3 (5.8) | <0.0001 |
| Hospital stay ± SD days | 11.2 ± 3.2 | 8.4 ± 2.4 | 0.03 |
| Pathological stage (III/II/I) | 45/6/0 (88.2/11.8/0) | 83/103/21 (40/49.8/10.2) | <0.0001 |
Comparisons of tumor localizations between groups
| Localizations | Emergent group | Elective group | P |
|---|---|---|---|
| Cecum or ascending colon | 14 (27.5) | 29 (13.9) |
|
| Transverse colon | 4 (7.9) | 19 (9.1) | 0.77 |
| Descending colon | 5 (9.8) | 11 (5.2) | 0.22 |
| Sigmoid or recto-sigmoid colon | 20 (39.7) | 52 (24.9) |
|
| Rectum | 8 (15.7) | 98 (46.9) |
|
Italic values indicate statistical significance
Comparisons of pathological stages between groups
| Stages | Emergent group | Elective group | P value |
|---|---|---|---|
| I | 0 (0) | 21 (10) | <0.0001 |
| II a | 1 (2) | 72 (34.4) | |
| II b | 3 (5.9) | 20 (9.7) | |
| II c | 3 (5.9) | 11 (5.3) | |
| III a | 0 (0) | 25 (11) | |
| III b | 21 (41.2) | 37 (17.7) | |
| III c | 23 (45.1) | 21 (10) |
Means and medians for survival time in groups
| Groups | Meana | Median | Overall comparison | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimate | SE | 95% confidence interval | Estimate | SE | 95% confidence interval | Log rank (Mantel Cox) | |||||
| Lower bound | Upper bound | Lower bound | Upper bound | Chi square |
| Sig | |||||
| Elective | 28,787 | 551 | 27,707 | 29,866 | – | – | – | – | |||
| Emergent | 18,599 | 1439 | 15,779 | 21,419 | 18,000 | 2303 | 13,486 | 22,514 | 69,269 | 1 | 0.000 |
| Overall | 27,381 | 590 | 26,224 | 28,537 | – | – | – | – | |||
aEstimation is limited to the largest survival time if it is censored
Fig. 2Estimated survival curves for two groups of patients in all stages
Fig. 3Estimated survival curves for two groups of patients in each stage (P < 0.05 for each comparisons)
Comparisons of outcomes between emergent and elective presentation of colorectal cancer in current literature
| Study | Country | Rate of emergency (%) | Hospital stay | Morbidity | 30 day mortality | Long term survival | Pathological stage |
|---|---|---|---|---|---|---|---|
| Our study | Turkey | 20 | Longer | Higher | Higher | Lower | Advanced |
| Hwang ( | Canada | 43 | Longer | NS | NS | NS | Advanced |
| Bass et al. ( | Ireland | 34 | NR | NR | Higher | Lower | Advanced |
| Sjo et al. ( | Norway | 25 | NR | Higher | Higher | NR | Advanced |
| Biondo et al. ( | Spain | 22 | Longer | NR | Higher | Lower | Advanced |
| Wong et al. ( | Australia | 19 | NR | NR | Higher | Lower | Advanced |
| Merkel et al. ( | Germany | 11 | NR | NR | Higher | Lower | Advanced |
| Coco et al. ( | Italy | 6 | Longer | Higher | NS | NS | Not |